Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Ormetoprim(OMP) Market by Type (?98.5%, <98.5%), By Application (Animals, Application II) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Ormetoprim(OMP) Market by Type (?98.5%, <98.5%), By Application (Animals, Application II) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 131868 3300 Chemical & Material 377 233 Pages 4.9 (35)

Market Overview:

The global ormetoprim market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for animal feed additives, increasing awareness about animal health and hygiene, and growing demand for organic meat products. However, the growth of the market could be restrained by factors such as stringent regulations governing the use of ormetoprim. The global ormetoprim market is segmented on the basis of type, application, and region.

Global Ormetoprim(OMP) Industry Outlook

Product Definition:

Ormetoprim is a sulfonamide antibiotic used to treat urinary tract infections. It is also used for prophylaxis of urinary tract infections in patients undergoing instrumentation.


?98.5% is a concentration of OMP used in the treatment of malaria, and has been found to be more effective than the traditional ?90% concentration. It is also used as an off-label drug for other diseases such as Chagas disease, American trypanosomiasis (sleeping sickness), and African trypanosomiasis (sleeping sickness).

98.5% is the concentration of OMP which has a better effect on patients with low or no fundus seen in first 24 hours and second-generation cephalosporin drugs are used for its treatment.

OMP is used to treat bacterial meningitis, bloodstream infections, septicaemia and pneumonia caused by various bacteria including K. pneumoniae (meningococcal meningitis), E. coli (septicaemia) and P.

Application Insights:

The animals segment held the largest share of more than 60.0% in 2017. The application of OMP is widespread for the treatment of various diseases in animals, such as swine dysentery, rinderpest, and salmonella infections in poultry. Moreover, it is also used to treat parasitic diseases caused by hookworms and Ascaris lumbricoides among other nematodes affecting humans such as trichuriasis or whipworm infection among children. Thus, rising importance on animal health coupled with increasing incidences of infectious diseases will drive demand over the forecast period.

Application II includes human use which accounted for a smaller market share due to high cost associated with its usage along with other antifungal agents like ketoconazole and itraconazole that are cheaper alternatives for treating fungal infections in humans without causing liver damage or interactions with other drugs (antibiotics).

Regional Analysis:

North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and high adoption rate for new therapies are some of the factors responsible for its large share. In addition, increasing number of animals affected with orthopedic disorders is expected to drive the regional market during the forecast period.

Asia Pacific is anticipated to be one of fastest-growing regions owing to rising healthcare expenditure and improving access due to rise in disposable income levels coupled with increase in government initiatives such as “Healthcare Reform” initiated by China's former president Jiang Zemin (1993). This initiative aims at universal coverage through private insurance system rather than relying on public health systems which would reduce overall healthcare costs over time; this has led Asia Pacific region poised for significant growth opportunities during the forecast period.

Growth Factors:

  • The increasing demand for antibiotics owing to the growing prevalence of infectious diseases is expected to drive the growth of the Ormetoprim market.
  • The rising awareness about the benefits of using antibiotics is anticipated to boost the demand for Ormetoprim products during the forecast period.
  • The increasing investment by pharmaceutical companies in research and development activities for new antibiotic drugs is projected to propel the growth of this market in future.
  • Growing number of mergers and acquisitions among key players is likely to provide impetus to this market over next few years.

Scope Of The Report

Report Attributes

Report Details

Report Title

Ormetoprim(OMP) Market Research Report

By Type

?98.5%, <98.5%

By Application

Animals, Application II

By Companies

PCCPL, Tianhe Pharmaceutical, CoreSyn, Yangzhou Winsome Aba Pharmacy, ...

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Ormetoprim(OMP) Market Report Segments:

The global Ormetoprim(OMP) market is segmented on the basis of:


?98.5%, <98.5%

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Animals, Application II

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. PCCPL
  2. Tianhe Pharmaceutical
  3. CoreSyn
  4. Yangzhou Winsome Aba Pharmacy
  5. ...

Global Ormetoprim(OMP) Market Overview

Highlights of The Ormetoprim(OMP) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. ?98.5%
    2. <98.5%
  1. By Application:

    1. Animals
    2. Application II
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Ormetoprim(OMP) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Ormetoprim(OMP) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Ormetoprim is an antibiotic used to treat a variety of infections, including pneumonia. It is also used to prevent or treat malaria.

Some of the key players operating in the ormetoprim(omp) market are PCCPL, Tianhe Pharmaceutical, CoreSyn, Yangzhou Winsome Aba Pharmacy.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Ormetoprim(OMP) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Ormetoprim(OMP) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Ormetoprim(OMP) Market - Supply Chain
   4.5. Global Ormetoprim(OMP) Market Forecast
      4.5.1. Ormetoprim(OMP) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Ormetoprim(OMP) Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Ormetoprim(OMP) Market Absolute $ Opportunity

5. Global Ormetoprim(OMP) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Ormetoprim(OMP) Market Size and Volume Forecast by Type
      5.3.1. ?98.5%
      5.3.2. <98.5%
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Ormetoprim(OMP) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Ormetoprim(OMP) Market Size and Volume Forecast by Application
      6.3.1. AnimalsII
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Ormetoprim(OMP) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Ormetoprim(OMP) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Ormetoprim(OMP) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Ormetoprim(OMP) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Ormetoprim(OMP) Demand Share Forecast, 2019-2029

9. North America Ormetoprim(OMP) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Ormetoprim(OMP) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Ormetoprim(OMP) Market Size and Volume Forecast by Application
      9.4.1. AnimalsII
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Ormetoprim(OMP) Market Size and Volume Forecast by Type
      9.7.1. ?98.5%
      9.7.2. <98.5%
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Ormetoprim(OMP) Demand Share Forecast, 2019-2029

10. Latin America Ormetoprim(OMP) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Ormetoprim(OMP) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Ormetoprim(OMP) Market Size and Volume Forecast by Application
      10.4.1. AnimalsII
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Ormetoprim(OMP) Market Size and Volume Forecast by Type
      10.7.1. ?98.5%
      10.7.2. <98.5%
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Ormetoprim(OMP) Demand Share Forecast, 2019-2029

11. Europe Ormetoprim(OMP) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Ormetoprim(OMP) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Ormetoprim(OMP) Market Size and Volume Forecast by Application
      11.4.1. AnimalsII
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Ormetoprim(OMP) Market Size and Volume Forecast by Type
      11.7.1. ?98.5%
      11.7.2. <98.5%
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Ormetoprim(OMP) Demand Share, 2019-2029

12. Asia Pacific Ormetoprim(OMP) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Ormetoprim(OMP) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Ormetoprim(OMP) Market Size and Volume Forecast by Application
      12.4.1. AnimalsII
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Ormetoprim(OMP) Market Size and Volume Forecast by Type
      12.7.1. ?98.5%
      12.7.2. <98.5%
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Ormetoprim(OMP) Demand Share, 2019-2029

13. Middle East & Africa Ormetoprim(OMP) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Ormetoprim(OMP) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Ormetoprim(OMP) Market Size and Volume Forecast by Application
      13.4.1. AnimalsII
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Ormetoprim(OMP) Market Size and Volume Forecast by Type
      13.7.1. ?98.5%
      13.7.2. <98.5%
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Ormetoprim(OMP) Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Ormetoprim(OMP) Market: Market Share Analysis
   14.2. Ormetoprim(OMP) Distributors and Customers
   14.3. Ormetoprim(OMP) Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. PCCPL Overview Financials Developments Strategic Outlook
      14.4.2. Tianhe Pharmaceutical Overview Financials Developments Strategic Outlook
      14.4.3. CoreSyn Overview Financials Developments Strategic Outlook
      14.4.4. Yangzhou Winsome Aba Pharmacy Overview Financials Developments Strategic Outlook
      14.4.5. ... Overview Financials Developments Strategic Outlook
      14.4.6. COMPANY6 Overview Financials Developments Strategic Outlook
      14.4.7. COMPANY7 Overview Financials Developments Strategic Outlook
      14.4.8. COMPANY8 Overview Financials Developments Strategic Outlook
      14.4.9. COMPANY9 Overview Financials Developments Strategic Outlook
      14.4.10. COMPANY 10 Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us